Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.46
High: 0.46
Low: 0.46
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Rights and Grant of Warrants

3 Feb 2016 07:00

RNS Number : 8563N
Haydale Graphene Industries PLC
03 February 2016
 

 

 

Haydale Graphene Industries plc

 

("Haydale", the "Group" or the "Company")

 

Acquisition of Rights to New Invention and Grant of Warrants

 

Haydale Graphene Industries plc (AIM: HAYD), the Group focused on enabling technology for the commercialisation of graphene and other nano materials, is pleased to announce it is exercising its rights under its existing pipeline agreement with Swansea University and Swansea Innovation Limited (together "Swansea") (the "Pipeline Agreement") to acquire a new invention (the "new invention").

 

The new invention relates to heatable articles, in particular clothing and bedding, incorporating carbon nanomaterial-based heaters. The flexibility, compact construction and thermal performance of the heaters means that the technology is envisaged as being of particular relevance to high performance garments for elite sports applications.

 

Pursuant to the terms of the Pipeline Agreement announced 25 February 2015 and by way of consideration for the acquisition of the new invention, the Company has agreed to grant the inventors, Tim Claypole and Swansea Innovation Limited, warrants over 30,000 ordinary share of 2 pence each in aggregate in the Company (the "Warrants"). Additionally, royalty income of 2% will be paid to Swansea Innovation Limited from any direct sales made by Haydale of the product or if the product is licensed, the revenue share will be Haydale 90% and Swansea Innovation Limited 10%.

 

All intellectual property rights in connection with the new invention have been assigned to the Group and the Group has filed a patent application to protect these rights.

 

The Warrants are exerciseable between the fourth and fifth anniversary of the date of grant. The exercise price of the Warrants is £2.735 per ordinary share (being the mid-market closing Haydale share price on 23 November 2015 plus £1). The warrants may be exercised in whole or in part.

 

Ray Gibbs, CEO at Haydale, commented:

 

"I am pleased to announce this second invention acquired from Swansea under the Pipeline Agreement. As previously stated, our strategy is to work with experts in our chosen market sectors to rapidly develop commercial products using our HDPlas™ functionalisation process. This announcement demonstrates that this strategy is working and we are optimistic that the new invention will further enhance Haydale's commercial opportunities in the application of graphene and carbon nano-materials."

 

Dr Gerry Ronan, Head of IP Commercialisation for Swansea University stated:

 

"We are delighted with how successful the Pipeline Agreement with Haydale Graphene Industries plc has become in such a short space of time. By incentivising all parties involved in research conducted at Swansea University we are now seeing the development of potentially commercially viable technologies from graphene. This partnership has been cemented with another patent application for a technology that we believe has huge commercial potential with multiple applications across many industries."

 

- Ends -

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman

David Banks

Will Goode

 

Hermes Financial PR

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

About Haydale

Haydale has developed a patented scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost-efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a low-pressure plasma process that treats both mined, organic fine powder and other synthetically produced nanomaterial powders, producing high-quality few layered graphenes and graphene nanoplatelets. The process can functionalise with a range of chemical groups, with the level of functionalisation tailored to the customer's needs. Good dispersion improves the properties and performance of the host material and ensures the final product performs as specified.

The Haydale plasma process does not use wet chemistry, nor does it damage the material being processed; rather, it can clean up any impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale process is an enabling technology, allowing the Company to work with a raw material producer who seeks to add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales and housed in a purpose-built facility for processing and handling nanomaterials, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, photovoltaics, composites, paints and coatings.

www.haydale.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSAFMEFMSEDE
Date   Source Headline
6th Oct 20227:00 amRNSFinal Results
20th Sep 20229:49 amRNSHolding(s) in Company
16th Sep 20227:00 amRNSDirector/PDMR Shareholding
15th Sep 20221:35 pmRNSDirector/PDMR Shareholding
13th Sep 20221:30 pmRNSBlock Admission Application
13th Sep 202210:30 amRNSResult of Open Offer
12th Sep 20221:27 pmRNSResult of General Meeting
7th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHaydale Has Food Packaging All Zipped Up
24th Aug 202210:17 amRNSResult of Fundraising
24th Aug 20229:00 amRNSPrice Monitoring Extension
23rd Aug 20224:37 pmRNSProposed Placing, Subscription and Open Offer
19th Aug 20224:41 pmRNSSecond Price Monitoring Extn
19th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
8th Aug 20224:41 pmRNSSecond Price Monitoring Extn
8th Aug 20224:36 pmRNSPrice Monitoring Extension
25th Jul 202210:25 amRNSHolding(s) in Company
19th Jul 20227:00 amRNSPost Period End Trading Update
8th Jul 20227:00 amRNSHaydale & Vittoria partner for innovation & supply
7th Jun 20227:00 amRNSTrading Update
30th May 20224:51 pmRNSChange of Auditor
12th May 20224:41 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
12th May 20222:06 pmRNSSecond Price Monitoring Extn
12th May 20222:00 pmRNSPrice Monitoring Extension
19th Apr 20227:00 amRNSHaydale Wins Awards for its Materials Technology
11th Apr 20227:00 amRNSAward of Grant to Develop Smart Composite Tooling
21st Mar 20227:00 amRNSNext Phase with Viritech
9th Mar 20227:00 amRNSSales Representation Agreement Signed
1st Mar 20225:26 pmRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNSRaising the Bar in Plastic Food Packaging
23rd Feb 20227:00 amRNSInterim Results
17th Feb 20227:00 amRNSContract to Develop Graphene Ink-Based Heaters
27th Jan 20227:00 amRNSHaydale Awarded Supply Agreement
21st Jan 20227:00 amRNSGrant of share options and PDMR dealings
12th Jan 20227:00 amRNSFunding to Develop Anti-Counterfeiting Technology
11th Jan 20222:14 pmRNSResult of AGM
11th Jan 20227:00 amRNSGNPs Enhance Clothing for iCraft and Pro-Specs
10th Jan 20227:00 amRNSChange of Adviser
24th Dec 202112:41 pmRNSSecond Price Monitoring Extn
24th Dec 202112:35 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSPosting of Annual Report and Notice of AGM
15th Dec 20217:16 amRNSFinal Results
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
10th Dec 20212:06 pmRNSSecond Price Monitoring Extn
10th Dec 20212:00 pmRNSPrice Monitoring Extension
5th Nov 20217:00 amRNSDate of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.